Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00221429 · ClinicalTrials.gov registry record · Phase 3
Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder
A Phase 3 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 3
- Development phase
- 153
- Enrollment target
NCT00221429 is a Phase 3 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 153 participants.
The verdict
NCT00221429, a Phase 3 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 153 participants
- Enrollment target
Study Summary
This study compared the efficacy of lithium, divalproex, and placebo in treating the acute phase of symptomatic bipolar I disorder, mixed or manic episode, in children and adolescents.
Interventions
- OTHER Placebo
- DRUG Lithium
- DRUG sodium divalproex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2001-03 |
| Est. Completion | 2015-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00221429
The ClinicalTrials.gov registry entry for NCT00221429 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00221429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00221429 about?
NCT00221429 is a clinical study titled "Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder". This study compared the efficacy of lithium, divalproex, and placebo in treating the acute phase of symptomatic bipolar I disorder, mixed or manic episode, in children and adolescents.
What is the current status of trial NCT00221429?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 153 participants. The study started on 2001-03. Estimated completion is 2015-02.
What interventions are being tested in trial NCT00221429?
The interventions under investigation include: Placebo (OTHER), Lithium (DRUG), sodium divalproex (DRUG).
Who is sponsoring clinical trial NCT00221429?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.